Clinical Trial Update: A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating fenfluramine hydrochloride for Rett syndrome, sponsored by UCB BIOSCIENCES, Inc., is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rett Syndrome

Drugs mentioned

• Fenfluramine hydrochloride (fenfluramine hydrochloride)

Snippet

Sponsor: UCB BIOSCIENCES, Inc. | Conditions: Rett Syndrome | Phase 3 | Status: NOT_YET_RECRUITING